121 related articles for article (PubMed ID: 14571791)
1. Low-dose cisplatin plus oral tegafur and uracil for the treatment of lung metastases of hepatocellular carcinoma.
Maeda T; Itasaka H; Takenaka K; Matsumata T; Shimada M; Ikeda T; Sugimachi K
Hepatogastroenterology; 2003; 50(53):1583-6. PubMed ID: 14571791
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
3. [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
Miyano M; Kurai O; Hiramatsu S; Yamasaki T; Sasaki E; Adachi K; Oka H
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1139-43. PubMed ID: 20567124
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
5. [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
Tanabe K; Taura K; Hatano E; Koyama Y; Takada Y; Uemoto S
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1077-80. PubMed ID: 23986055
[TBL] [Abstract][Full Text] [Related]
6. A new chemotherapeutic regimen for advanced unresectable hepatocellular carcinoma.
Seki S; Yamada T; Kawakita N; Masuichi H; Kitada T; Sakaguchi H
Hepatogastroenterology; 2003; 50(53):1598-602. PubMed ID: 14571794
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Hsu CY; Shen YC; Yu CW; Hsu C; Hu FC; Hsu CH; Chen BB; Wei SY; Cheng AL; Shih TT
J Hepatol; 2011 Oct; 55(4):858-65. PubMed ID: 21338641
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastases.
Katamura Y; Aikata H; Hashimoto Y; Kimura Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Chayama K
Hepatogastroenterology; 2010; 57(102-103):1272-8. PubMed ID: 21410071
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil.
Tsuchiya A; Imai M; Kamimura H; Togashi T; Watanabe K; Seki K; Ishikawa T; Ohta H; Yoshida T; Kamimura T
World J Gastroenterol; 2009 Apr; 15(14):1779-81. PubMed ID: 19360925
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer.
Ichinose Y; Takanashi N; Yano T; Asoh H; Yokoyama H; Tayama K; Hara N; Ohta M
Cancer; 1995 Jun; 75(11):2677-80. PubMed ID: 7743469
[TBL] [Abstract][Full Text] [Related]
12. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
Yano T; Koga T; Nomiyama H; Hidaka H
Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
[TBL] [Abstract][Full Text] [Related]
13. Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Ichinose Y; Nakai Y; Kudoh S; Semba H; Yoshida S; Nukiwa T; Yamamoto H; Yamane Y; Niitani H
Clin Cancer Res; 2004 Jul; 10(13):4369-73. PubMed ID: 15240524
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
Ishikawa T; Ichida T; Ishimoto Y; Yokoyama J; Nomoto M; Ebe Y; Usuda H; Naito M; Asakura H
Am J Gastroenterol; 1999 Jun; 94(6):1682-5. PubMed ID: 10364045
[TBL] [Abstract][Full Text] [Related]
15. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
[TBL] [Abstract][Full Text] [Related]
17. Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
Kanaji N; Bandoh S; Ishida T
South Med J; 2007 Oct; 100(10):1056-7. PubMed ID: 17943058
[No Abstract] [Full Text] [Related]
18. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Asano N; Fukano M; Kubo M; Sato J; Ito A; Inoue T; Tsujikawa T; Ando A; Sasaki M; Yoshioka U; Koyama S; Fujiyama Y; Bamba T
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1069-73. PubMed ID: 9644322
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
20. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Kim SJ; Seo HY; Choi JG; Sul HR; Sung HJ; Park KH; Choi IK; Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2006 Apr; 57(4):436-42. PubMed ID: 16049620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
